VC firm
XGen Ventures
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Founded
- 2021
Claim, correct or request removal
Record updated 30 September 2026
About
At XGEN we specialize in early stage investments in private research & development companies in the life sciences sector.
Investment approach
- Thesis
- We are here to build next generation life science ventures.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- Federica is Managing Partner of XGEN Venture and currently serves on the boards of EpilepsyGTx, Protembis, Aavantgarde and InnovHeart.
- Investing status notes
- The XGEN team is currently investing out of its first fund, XGEN Venture Life Science Fund launched at the end of 2022, while it continues to advise Genextra’s board of directors on the management of its portfolio.
Loading relationship preview